Interested in participating? Learn about a clinical study opportunity.

At Ultragenyx, our goal is to bring novel therapies to individuals with serious rare and ultra-rare genetic diseases. All our efforts—from translational research to clinical development to patient access programs—are rooted in our commitment to provide individuals and their families with hope today. We put individuals and their caregivers at the center of our work, involving them at all stages of therapeutic development. This provides us with an understanding of the impact a disease has on an individual—biologically, functionally, and emotionally—so we can support the entire person and not just their symptoms.

Visit clinicaltrials.gov to see which trials we are currently supporting.

To speak with a PEL about current and future medical research opportunities, please email our PEL team at [email protected]

General Inquiry

To learn about current and future studies, you only need to fill out the form once.
*All fields are required.

 

If you would like to know more about your privacy and the data you submit and data we collect while you are on this website, please see below or visit our privacy policy.

What happens after you submit your information?

Our Patient Enrollment Liaison (PEL) team will contact you by email or phone within one business day to discuss your study eligibility and answer questions.

If you choose to be contacted by email, be sure to check your spam folder for an email from [email protected], if it’s not in your regular inbox.

Email icon

Got Questions?

Email our PEL team about current and future medical research opportunities.

Please Enter Only US Phone Number

We will get backto shortly